44.192.16.60
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Neurology

Discontinuing high-efficacy therapy for older patients with MS raises relapse risk

A recent observational cohort study sheds light on the risks associated with discontinuing high-efficacy therapy (HET) for older patients with nonactive multiple sclerosis (MS). The findings provide crucial insights into treatment strategies for this demographic group. Below are the main takeaways. Discontinuing High-Efficacy Therapy (HET) Poses Risks: Stopping HET for...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-